These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9665256)

  • 1. Increased acute and chronic mitotic activity in rat laryngeal muscles after botulinum toxin injection.
    Inagi K; Connor NP; Schultz E; Ford CN; Cook CH; Bless DM; Heisey DM
    Laryngoscope; 1998 Jul; 108(7):1055-61. PubMed ID: 9665256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic assessment of botulinum toxin effects in the rat larynx.
    Inagi K; Connor NP; Ford CN; Schultz E; Rodriquez AA; Bless DM; Pasic T; Heisey DM
    Laryngoscope; 1998 Jul; 108(7):1048-54. PubMed ID: 9665255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle fiber-type changes induced by botulinum toxin injection in the rat larynx.
    Inagi K; Connor NP; Schultz E; Ford CN; Cook CH; Heisey DM
    Otolaryngol Head Neck Surg; 1999 Jun; 120(6):876-83. PubMed ID: 10352443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
    Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia.
    Damrose JF; Goldman SN; Groessl EJ; Orloff LA
    J Voice; 2004 Sep; 18(3):415-22. PubMed ID: 15331116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 7. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1995 Feb; 24(1):64-8. PubMed ID: 7769649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin Injections Into the Lateral Cricoarytenoid Muscles for Vocal Process Granuloma.
    Pham Q; Campbell R; Mattioni J; Sataloff R
    J Voice; 2018 May; 32(3):363-366. PubMed ID: 28778373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
    Inagi K; Rodriquez AA; Ford CN; Heisey DM
    Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection in laryngeal dyspnea.
    Woisard V; Liu X; Bes MC; Simonetta-Moreau M
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):909-917. PubMed ID: 27600559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.
    Truong DD; Bhidayasiri R
    Eur J Neurol; 2006 Feb; 13 Suppl 1():36-41. PubMed ID: 16417596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
    J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of repeated botulinum toxin injections as a function of timing.
    Inagi K; Ford CN; Rodriquez AA; Schultz E; Bless DM; Heisey DM
    Ann Otol Rhinol Laryngol; 1997 Dec; 106(12):1012-9. PubMed ID: 9415596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A.
    Guntinas-Lichius O
    Laryngoscope; 2003 Apr; 113(4):743-5. PubMed ID: 12671439
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal electromyography in movement disorders: preliminary data.
    Kimaid PA; Quagliato EM; Crespo AN; Wolf A; Viana MA; Resende LA
    Arq Neuropsiquiatr; 2004 Sep; 62(3A):741-4. PubMed ID: 15334243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of therapeutic botulinum toxin preparations.
    Dressler D; Benecke R
    Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EMG support in botulinum toxin treatment].
    Monnier G; Parratte B; Tatu L; Cosson A; Michel F; Metton G
    Ann Readapt Med Phys; 2003 Jul; 46(6):380-5. PubMed ID: 12928146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
    Bielamowicz S; Ludlow CL
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.